These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 35212350)

  • 21. Ginsenoside Rh2-Based Multifunctional Liposomes for Advanced Breast Cancer Therapy.
    Hong C; Wang A; Xia J; Liang J; Zhu Y; Wang D; Zhan H; Feng C; Jiang X; Pan J; Wang J
    Int J Nanomedicine; 2024; 19():2879-2888. PubMed ID: 38525007
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The potential efficacy of R8-modified paclitaxel-loaded liposomes on pulmonary arterial hypertension.
    Yin Y; Wu X; Yang Z; Zhao J; Wang X; Zhang Q; Yuan M; Xie L; Liu H; He Q
    Pharm Res; 2013 Aug; 30(8):2050-62. PubMed ID: 23756757
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design, preparation and evaluation of different branched biotin modified liposomes for targeting breast cancer.
    Tang B; Peng Y; Yue Q; Pu Y; Li R; Zhao Y; Hai L; Guo L; Wu Y
    Eur J Med Chem; 2020 May; 193():112204. PubMed ID: 32172035
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preparation, Characterization, and Pharmacokinetic Study of a Novel Long-Acting Targeted Paclitaxel Liposome with Antitumor Activity.
    Han B; Yang Y; Chen J; Tang H; Sun Y; Zhang Z; Wang Z; Li Y; Li Y; Luan X; Li Q; Ren Z; Zhou X; Cong D; Liu Z; Meng Q; Sun F; Pei J
    Int J Nanomedicine; 2020; 15():553-571. PubMed ID: 32158208
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of two methods for tumour-targeting peptide modification of liposomes.
    Huang SQ; Zhang HM; Zhang YC; Wang LY; Zhang ZR; Zhang L
    Acta Pharmacol Sin; 2023 Apr; 44(4):832-840. PubMed ID: 36271156
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dual Receptor Targeting Cell Penetrating Peptide Modified Liposome for Glioma and Breast Cancer Postoperative Recurrence Therapy.
    Qiu Y; Yu Q; Liu Y; Tang J; Wang X; Lu Z; Xu Z; He Q
    Pharm Res; 2018 Apr; 35(7):130. PubMed ID: 29700620
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fructose and biotin co-modified liposomes for dual-targeting breast cancer.
    Li R; Peng Y; Pu Y; Zhao Y; Nie R; Guo L; Wu Y
    J Liposome Res; 2022 Jun; 32(2):119-128. PubMed ID: 34895001
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Folic Acid and Poly(ethylene glycol) Decorated Paclitaxel Nanocrystals Exhibit Enhanced Stability and Breast Cancer-Targeting Capability.
    Zhao J; Du J; Wang J; An N; Zhou K; Hu X; Dong Z; Liu Y
    ACS Appl Mater Interfaces; 2021 Mar; 13(12):14577-14586. PubMed ID: 33728919
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of the efficacy and safety of a new formulation-lipid emulsion-based PTX injection: Pharmacokinetics, tissue distributions and anticancer effect on human gastric cancer cells in vitro.
    Fei Y; Wang Y; Wu S; Shen F; Fan G
    Biomed Chromatogr; 2021 Aug; 35(8):e5107. PubMed ID: 33651440
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro and in vivo studies of different liposomes containing topotecan.
    Hao YL; Deng YJ; Chen Y; Wang XM; Zhong HJ; Suo XB
    Arch Pharm Res; 2005 May; 28(5):626-35. PubMed ID: 15974453
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sequential Targeting Hybrid Nanovesicles Composed of Chimeric Antigen Receptor T-Cell-Derived Exosomes and Liposomes for Enhanced Cancer Immunochemotherapy.
    Zhu T; Chen Z; Jiang G; Huang X
    ACS Nano; 2023 Sep; 17(17):16770-16786. PubMed ID: 37624742
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improved Antitumor Activity of Novel Redox-Responsive Paclitaxel-Encapsulated Liposomes Based on Disulfide Phosphatidylcholine.
    Du Y; Wang Z; Wang T; He W; Zhou W; Li M; Yao C; Li X
    Mol Pharm; 2020 Jan; 17(1):262-273. PubMed ID: 31747284
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Polysialic acid-functionalized liposomes for efficient honokiol delivery to inhibit breast cancer growth and metastasis.
    Li X; Guan S; Li H; Li D; Liu D; Wang J; Zhu W; Xing G; Yue L; Cai D; Zhang Q
    Drug Deliv; 2023 Dec; 30(1):2181746. PubMed ID: 36803115
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantitative proteomic analysis to the first commercialized liposomal paclitaxel nano-platform Lipusu revealed the molecular mechanism of the enhanced anti-tumor effect.
    Zhao M; Li H; Fan L; Ma Y; Gong H; Lai W; Fang Q; Hu Z
    Artif Cells Nanomed Biotechnol; 2018; 46(sup3):S147-S155. PubMed ID: 30231644
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biotin and glucose dual-targeting, ligand-modified liposomes promote breast tumor-specific drug delivery.
    Huang M; Pu Y; Peng Y; Fu Q; Guo L; Wu Y; Zheng Y
    Bioorg Med Chem Lett; 2020 Jun; 30(12):127151. PubMed ID: 32317211
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Liposomes modified with double-branched biotin: A novel and effective way to promote breast cancer targeting.
    Lu R; Zhou L; Yue Q; Liu Q; Cai X; Xiao W; Hai L; Guo L; Wu Y
    Bioorg Med Chem; 2019 Jul; 27(14):3115-3127. PubMed ID: 31155297
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Engineered breast tumor targeting peptide ligand modified liposomal doxorubicin and the effect of peptide density on anticancer activity.
    Shahin M; Soudy R; Aliabadi HM; Kneteman N; Kaur K; Lavasanifar A
    Biomaterials; 2013 May; 34(16):4089-4097. PubMed ID: 23465829
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improved tumor-targeting drug delivery and therapeutic efficacy by cationic liposome modified with truncated bFGF peptide.
    Chen X; Wang X; Wang Y; Yang L; Hu J; Xiao W; Fu A; Cai L; Li X; Ye X; Liu Y; Wu W; Shao X; Mao Y; Wei Y; Chen L
    J Control Release; 2010 Jul; 145(1):17-25. PubMed ID: 20307599
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PEGylated hyaluronic acid-coated liposome for enhanced in vivo efficacy of sorafenib via active tumor cell targeting and prolonged systemic exposure.
    Mo L; Song JG; Lee H; Zhao M; Kim HY; Lee YJ; Ko HW; Han HK
    Nanomedicine; 2018 Feb; 14(2):557-567. PubMed ID: 29248675
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hyaluronic acid-modified liposomal honokiol nanocarrier: Enhance anti-metastasis and antitumor efficacy against breast cancer.
    Wang J; Liu D; Guan S; Zhu W; Fan L; Zhang Q; Cai D
    Carbohydr Polym; 2020 May; 235():115981. PubMed ID: 32122511
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.